Reverse transcription recombinase-aided amplification assay for avian influenza virus

Virus Genes. 2023 Jun;59(3):410-416. doi: 10.1007/s11262-023-01979-z. Epub 2023 Feb 13.

Abstract

Avian influenza virus (AIV) infection can lead to severe economic losses in the poultry industry and causes a serious risk for humans. A rapid and simple test for suspected viral infection cases is crucial. In this study, a reverse transcription recombinase-aided amplification assay (RT-RAA) for the rapid detection of all AIV subtypes was developed. The reaction temperature of the assays is at 39 °C and the detection process can be completed in less than 20 min. The specificity results of the assay showed that this method had no cross-reaction with other main respiratory viruses that affect birds, including Newcastle disease virus (NDV) and infectious bronchitis virus (IBV). The analytical sensitivity at a 95% confidence interval was 102 RNA copies per reaction. In comparison with a published assay for reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR), the κ value of the RT-RAA assay in 384 avian clinical samples was 0.942 (p < 0.001). The sensitivity and specificity of the RT-RAA assay for avian clinical sample detection was determined as 97.59% (95% CI 93.55-99.23%) and 96.79% (95% CI 93.22-98.59%), respectively. The RT-RAA assay for AIV in this study provided an effective and practicable tool for AIV molecular detection.

Keywords: Avian influenza virus; Reverse transcription recombinase-aided amplification assay; Sensitivity; Specificity.

MeSH terms

  • Animals
  • Birds / genetics
  • Humans
  • Influenza A virus* / genetics
  • Influenza in Birds* / diagnosis
  • Recombinases / genetics
  • Recombinases / metabolism
  • Reverse Transcription
  • Sensitivity and Specificity

Substances

  • Recombinases